Broadridge Financial Solutions, Inc. (NYSE:BR) announced that Pershing Securities Australia Limited, part of BNY Mellon, has selected Broadridge’s Australian post-trade processing solution as its new middle- and back-office processing platform for third-party domestic clearing. The solution is designed to increase process efficiencies and provide flexibility to support forthcoming market and regulatory changes based on a modern platform. On Monday shares of Broadridge Financial Solutions, Inc. (NYSE:BR) closed at $48.47. Company’s sales growth for last 5 years was 4.30% and EPS growth for next 5 years is recorded as 12.00%.
Medtronic plc (NYSE: MDT) announced CE (Conformité Européene) Mark for the 26 mm and 29 mm sizes of the CoreValve®Evolut(TM)R System a next generation self-expanding valve that advances performance and deliverability during transcatheter aortic valve implantation (TAVI) while providing the option to recapture (re-sheath the valve back into the catheter) and reposition (move the valve to a new position either above or below its current placement) the valve during procedures. Medtronic plc (NYSE:MDT) in last trading activity moved up 1.25% to close at $72.29. Company weekly performance is -4.37% while its quarterly performance stands at 7.65%. Medtronic plc (NYSE:MDT) is -6.59% away from its 52 week high.
Spectra Energy Corp and Spectra Energy Partners (NYSE:SEP) will discuss their business outlook and 2015-2017 financial plan during an analyst/investor meeting on Thursday, February 5, 2015. On last trading day Spectra Energy Partners, LP (NYSE:SEP) moved up 1.38% to close at $55.10. Its volatility for the week is 2.78% while volatility for the month is 3.19%. SEP’s sales growth for past 5 years was 73.50% and its EPS growth for past 5 years was 38.60%. Spectra Energy Partners, LP (NYSE:SEP) monthly performance is -3.28%.
Reliv International, Inc. (NASDAQ:RELV) has 36.89% insider ownership while its institutional ownership stands at 7.10%. In last trading activity company’s stock closed at $1.20.
Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), announced that it has promoted John Saharek to Chief Commercial Officer and Andrew R. Boll to Chief Financial Officer. On last trading day Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) moved up 1.95% to close at $7.51. Its volatility for the week is 3.27% while volatility for the month is 4.96%. IMMY’s EPS growth for past 5 years was 37.10%. Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) monthly performance is 0.19%.